Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Core Insights - Akoya Biosciences is expanding its product offerings with new ultrahigh-plex neurobiology panels for human and mouse applications, building on the success of the Human IO60 and Mouse FFPE IO panels [1][2] - The new panels aim to provide comprehensive spatial insights in neuroscience research, particularly in understanding neurodegenerative diseases and therapeutic development [2][6] - The company emphasizes its leadership in spatial biology and aims to capture a growing market segment through these innovations [1][4] Product Features - The Human Neurobiology Panel includes a wide range of biomarkers to study neurodegenerative diseases, neuroinflammation, and therapeutic targets, making it essential for neuroscience research [6] - The Mouse Neurobiology Panel is optimized for preclinical studies, offering deep biomarker insights to support disease modeling and translational applications [6] - Both panels are fully integrated with the PhenoCycler-Fusion platform, enhancing speed and resolution in spatial proteomics [6] Market Impact - The PhenoCode™ Discovery IO60 panel has been well-received by key opinion leaders and contract research organizations for its ability to provide deep insights into immune landscapes [2][5] - Strategic partnerships with leading CROs have facilitated the adoption of the IO60 panel, making advanced spatial proteomics more accessible to researchers [5] - The expansion of the product menu is attributed to the efficiency of Akoya's Manufacturing Center of Excellence, which supports the company's growth in various market segments [4]